Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin
about
Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer LesionsThe combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infectionGenotyping Tools for Mycobacterium ulcerans-Drawbacks and Future ProspectsPrimary cultivation: factors affecting contamination and Mycobacterium ulcerans growth after long turnover time of clinical specimens.Genetic diversity of Staphylococcus aureus in Buruli ulcer.Immunohistochemical monitoring of wound healing in antibiotic treated Buruli ulcer patients.Mycobacterial skin and soft tissue infection.Treatment Outcome of Patients with Buruli Ulcer Disease in Togo.Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis.Cultural Understanding of Wounds, Buruli Ulcers and Their Management at the Obom Sub-district of the Ga South Municipality of the Greater Accra Region of Ghana.Assessing and managing wounds of Buruli ulcer patients at the primary and secondary health care levels in Ghana.Possible healthcare-associated transmission as a cause of secondary infection and population structure of Staphylococcus aureus isolates from two wound treatment centres in Ghana.History, biology and chemistry of Mycobacterium ulcerans infections (Buruli ulcer disease).Bacterial diversity in Buruli ulcer skin lesions: Challenges in the clinical microbiome analysis of a skin diseaseEffect of secondary infection on epithelialisation and total healing of cutaneous leishmaniasis lesions.Antimicrobial resistance in Africa: a systematic review.The chemistry and biology of mycolactones.Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.Support needs of people living with Mycobacterium ulcerans (Buruli ulcer) disease in a Ghana rural community: a grounded theory study.Effect of secondary infection on epithelialisation and total healing of cutaneous leishmaniasis lesions.Adhesion of the ulcerative pathogen Mycobacterium ulcerans to DACC-coated dressings.Implementing active community-based surveillance-response system for Buruli ulcer early case detection and management in Ghana
P2860
Q27318699-7B62604D-0424-4633-B96A-9F8088E1DF5DQ31166470-324D6995-FDA0-498C-BDBA-147A39717F28Q33693727-95E9CC09-4CF2-4F43-916A-EA2F24F8DCA9Q34687435-9FCA6FFF-8937-4ABF-959D-1CCEF6CBC755Q35058098-9C2DB080-8F57-4994-8684-3907B7C865A5Q35156761-13231305-844B-47C8-A547-9F9BA919D737Q35359858-2E0E1E85-54BE-49FC-84FD-43E26B8107EFQ35810457-EC337152-033C-409B-AEF1-598DA402ACB1Q35933855-AC8E416B-BD03-4092-97EE-3203F048C56AQ36037938-3F7585EF-211C-40ED-9A98-9ABA3DD0F373Q36082869-1514B020-D980-4415-9B53-6BDCC04C2B7AQ36292804-19C29E99-5CAF-4B5A-AA82-F3FDEEF09E88Q37171686-E3B56C67-ED6D-4E5E-8D0D-72368509A1A1Q38157768-26697DFD-E128-44EE-818F-3DF64772DD3FQ39551255-493DE731-AD09-43C2-A793-C6076905840DQ40049237-66480579-AD7A-4FC5-B368-85D87E72517CQ40053352-721F4266-803B-4E2F-BF20-7C02927238A8Q41469222-F796CBC2-DC47-48BB-8917-E478C9E41F62Q46241939-D667B0B7-780D-404F-9957-12E3657F9057Q46782562-1951D943-86D8-4AFF-9CA7-27775C229A28Q47146480-95587A91-DAD7-425D-BE61-161E776FA397Q53469363-A3D8875E-04D8-4F0C-803A-A92A3327F890Q58745979-132352A5-729D-4107-865B-32242EEC43D8
P2860
Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Secondary bacterial infections ...... th streptomycin and rifampicin
@ast
Secondary bacterial infections ...... th streptomycin and rifampicin
@en
Secondary bacterial infections ...... th streptomycin and rifampicin
@nl
type
label
Secondary bacterial infections ...... th streptomycin and rifampicin
@ast
Secondary bacterial infections ...... th streptomycin and rifampicin
@en
Secondary bacterial infections ...... th streptomycin and rifampicin
@nl
prefLabel
Secondary bacterial infections ...... th streptomycin and rifampicin
@ast
Secondary bacterial infections ...... th streptomycin and rifampicin
@en
Secondary bacterial infections ...... th streptomycin and rifampicin
@nl
P2093
P2860
P50
P3181
P1476
Secondary bacterial infections ...... th streptomycin and rifampicin
@en
P2093
Albert Paintsil
Benjamin Anku
Cynthia Kwakye-Maclean
Evelyn Owusu-Mireku
Grace S Kpeli
Isaac Lamptey
Kobina Asan-Ampah
Kwabena Quenin-Fosu
Marie-Thérèse Ruf
Mercy Newman
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0002191
P407
P577
2013-01-01T00:00:00Z